Nihon Medi-Physics Attains World's First Manufacturing of Acti...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TOKYO, Apr. 5, 2022 /Kyodo JBN-AsiaNet/ -- - Core Material Used for Targeted Alpha Therapy (TAT) Expected to Be Novel Treatment for Cancer -Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company in Japan, announced on April 5, 2022, that the company has successfully ...
Authors: LATEST ASIANET NEWS RELEASES